Regulatory mechanism and therapeutic potentials of naringin against inflammatory disorders
Heliyon, ISSN: 2405-8440, Vol: 10, Issue: 3, Page: e24619
2024
- 11Citations
- 49Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations11
- Citation Indexes11
- CrossRef11
- 11
- Captures49
- Readers49
- 49
- Mentions1
- News Mentions1
- 1
Most Recent News
New Science and Technology Study Findings Recently Were Reported by Researchers at Shandong University of Traditional Chinese Medicine (Regulatory mechanism and therapeutic potentials of naringin against inflammatory disorders)
2024 FEB 14 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Science Daily -- New study results on science and technology have been
Review Description
Naringin is a natural flavonoid with therapeutic properties found in citrus fruits and an active natural product from herbal plants. Naringin has become a focus of attention in recent years because of its ability to actively participate in the body's immune response and maintain the integrity of the immune barrier. This review aims to elucidate the mechanism of action and therapeutic efficacy of naringin in various inflammatory diseases and to provide a valuable reference for further research in this field. The review provided the chemical structure, bioavailability, pharmacological properties, and pharmacokinetics of naringin and found that naringin has good therapeutic potential for inflammatory diseases, exerting anti-inflammatory, anti-apoptotic, anti-oxidative stress, anti-ulcerative and detoxifying effects in the disease. Moreover, we found that the great advantage of naringin treatment is that it is safe and can even alleviate the toxic side effects associated with some of the other drugs, which may become a highlight of naringin research. Naringin, an active natural product, plays a significant role in systemic diseases' anti-inflammatory and antioxidant regulation through various signaling pathways and molecular mechanisms.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2405844024006509; http://dx.doi.org/10.1016/j.heliyon.2024.e24619; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85183501347&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/38317884; https://linkinghub.elsevier.com/retrieve/pii/S2405844024006509; https://dx.doi.org/10.1016/j.heliyon.2024.e24619
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know